MAIA Biotechnology (MAIA) is scheduled to report Q2 earnings on August 10, 2026. Analysts estimate EPS of $-0.22 and quarterly revenue of N/A.
In the most recent quarter (Q1), MAIA Biotechnology reported EPS of $-0.14, beating estimates of $-0.18 by 0.22%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
MAIA Biotechnology has beaten EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, MAIA Biotechnology has averaged an EPS surprise of 0.49% and a revenue surprise of 0.00%.
Analyze the earnings history of MAIA Biotechnology using advanced sorting and filters.
The chart below shows MAIA Biotechnology's reported EPS compared to analyst estimates over recent quarters.
The chart below shows MAIA Biotechnology's reported revenue compared to analyst estimates over recent quarters.
MAIA Biotechnology (MAIA) is scheduled to report earnings on August 10, 2026. The last reported earnings were for reported on May 11, 2026 for Q1.
The Actual EPS was $-0.14, which beat the estimate of $-0.18.
The Actual Revenue was $0.00, which hit the estimate of $0.00.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2026-05-11 | $-0.14 | $-0.18 | 22.2 % |
| Q4 | 2026-03-23 | $-0.08 | $-0.13 | 38.5 % |
| Q3 | 2025-11-07 | $-0.27 | $-0.13 | -107.7 % |
| Q2 | 2025-08-11 | $-0.18 | $-0.21 | 28.0 % |